sorafenib has been researched along with Diffuse Large B-Cell Lymphoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| An, YH; Sun, WDBMCBAPC; Tong, XM; Wang, X; Zhou, Y | 1 |
| Gascoyne, RD; Go, RS; Greenwald, DR; Horning, S; Kahl, BS; King, D; Kolesar, J; Li, H; Luger, SM; Patel, T | 1 |
| Dent, P; Fisher, RI; Friedberg, J; Grant, S; Jordan, N; Nguyen, TK | 1 |
1 trial(s) available for sorafenib and Diffuse Large B-Cell Lymphoma
| Article | Year |
|---|---|
A phase II study of sorafenib (BAY 43-9006) in recurrent diffuse large B cell lymphoma: an eastern cooperative oncology group study (E1404).
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Niacinamide; Phenylurea Compounds; Prognosis; Sorafenib; Treatment Outcome | 2013 |
2 other study(ies) available for sorafenib and Diffuse Large B-Cell Lymphoma
| Article | Year |
|---|---|
[Mechanism of Sorafenib and Decitabine Inducing Apoptosis of Diffuse Large B-Cell Lymphoma Cells].
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Decitabine; Humans; Lymphoma, Large B-Cell, Diffuse; Phosphatidylinositol 3-Kinases; Sorafenib | 2020 |
Inhibition of MEK/ERK1/2 sensitizes lymphoma cells to sorafenib-induced apoptosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Benzenesulfonates; Blotting, Western; Cell Line, Tumor; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Humans; Lymphoma, Large B-Cell, Diffuse; MAP Kinase Kinase Kinases; Niacinamide; Phenylurea Compounds; Pyridines; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Sorafenib; Transfection | 2010 |